Patents by Inventor Ian K. McNiece

Ian K. McNiece has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bone Marrow Derived CD271 Precursor Cells for Cardiac Repair
    Publication number: 20230071551
    Abstract: Methods for the isolation of CD271+ stem cell populations are important in the prevention or treatment of cardio-vascular diseases and repair of cardiac tissue. The methods are applicable to stem cells from different sources and can be used to treat or prevent diseases or repair of tissues elsewhere in the organism's body.
    Type: Application
    Filed: July 8, 2022
    Publication date: March 9, 2023
    Inventors: Joshua M. Hare, Ian K. McNiece
  • BONE MARROW DERIVED CD271 PRECURSOR CELLS FOR CARDIAC REPAIR
    Publication number: 20140023621
    Abstract: Methods for the isolation of CD271+ stem cell populations are important in the prevention or treatment of cardio-vascular diseases and repair of cardiac tissue. The methods are applicable to stem cells from different sources and can be used to treat or prevent diseases or repair of tissues elsewhere in the organism's body.
    Type: Application
    Filed: August 29, 2011
    Publication date: January 23, 2014
    Applicant: University of Miami
    Inventors: Joshua M. Hare, Ian K. McNiece
  • Preparation And Use Of Stromal Cells For Treatment Of Cardiac Diseases
    Publication number: 20110195054
    Abstract: This invention is directed to the preparation and use of stromal cells for treatment of cardiac tissue.
    Type: Application
    Filed: October 6, 2010
    Publication date: August 11, 2011
    Inventors: Michael Cohen, Ian K. McNiece
  • ISOLATION OF STEM CELL PRECURSORS AND EXPANSION IN NON-ADHERENT CONDITIONS
    Publication number: 20110182866
    Abstract: Stem cells and compositions thereof are isolated, cultured and expanded. Culture conditions and methods of culturing the isolated stem cells provide non-adherent stem cells which are prophylactically and therapeutically more effective in patients, diagnostics, screening assays and other stem cell uses.
    Type: Application
    Filed: May 14, 2009
    Publication date: July 28, 2011
    Applicant: UNIVERSITY OF MIAMI
    Inventor: Ian K. Mcniece
  • Hemolymphopoietic growth factors, process for purifying and producing hemolymphopoietic growth factors and pharmaceutical compositions made therefrom
    Patent number: 5264418
    Abstract: This invention relates to hemolymphopoeitic growth factors (HLGF-1) that synergize with CSF-1, IL3 and GM-CSF and have pre-B cell potentiating activity. The invention also relates to a process for purifying such HLGF-1's from murine marrow cells and for producing such HLGF-1s by hosts transformed with recombinant DNA molecules comprising DNA sequences encoding the growth factor, and to methods of treatment and compositions characterized by HLGF-1s. These methods and agents are useful in immunoregulatory and hemopoietic applications and therapies.
    Type: Grant
    Filed: December 3, 1987
    Date of Patent: November 23, 1993
    Assignee: The University of Virginia Alumni Patents Foundation
    Inventors: Peter J. Quesenberry, Ian K. McNiece